Publications by authors named "Ruby John Anto"

Claim this Profile
T
Targeting BRF2: insights from screening and molecular dynamic simulations.
Anuranjan Singh Rathore, Krishna Kant Gupta, Senthil Kumar Govindaraj, Abhishek Ajmani, Jaison Arivalagan, Ruby John Anto

J Biomol Struct Dyn· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated 'Orphan Drug', for the Treatment of Hepatocellular Carcinoma.
Chenicheri Kizhakkeveettil Keerthana, Sreekumar U Aiswarya, Tennyson P Rayginia, Yadu Vijayan, Shirly James, Ruby John Anto

Anticancer Agents Med Chem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma.
Tennyson Prakash Rayginia, Chenicheri Kizhakkeveettil Keerthana, Sadiq Chembothumparambil Shifana, Maria Joy Pellissery, Ajmani Abhishek, Ruby John Anto

Curr Med Chem· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced extracellular vesicles mediated uttroside B (Utt-B) delivery to Hepatocellular carcinoma cell: Pharmacokinetics based on PBPK modelling.
Kalimuthu Kalishwaralal, Abdul Azeez Nazeer, D K Induja, Chenicheri K Keerthana, Sadiq C Shifana, Ruby John Anto

Biochem Biophys Res Commun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy.
Nair Hariprasad Haritha, Akbar Nawab, Vinod Vijayakurup, Nikhil Ponnoor Anto, Vijayasteltar B Liju, Ruby John Anto

Front Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy.
Cijo George Vazhappilly, Shoib Sarwar Siddiqui, Ruby John Anto, Rajan Radhakrishnan, Naveen Kumar Devanga Ragupathi

Front Pharmacol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Role of extracellular vesicles (EVs) in pathogenesis, diagnosis, therapeutic delivery, treatment and theranostic applications in cancer.
Reza Shahbazi, Kalimuthu Kalishwaralal, Manash K Paul, Ruby John Anto

Front Bioeng Biotechnol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Curcuminoids: their pleiotropism against hallmarks of cancers.
Daniel L Pouliquen, Koraljka Gall Trošelj, Ruby John Anto, Rakesh Naidu

Front Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma.
Mohan Shankar Gopinatha Pillai, Sreekumar U Aiswarya, Chenicheri K Keerthana, Tennyson P Rayginia, Ruby John Anto

iScience· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Curcuminoids as Anticancer Drugs: Pleiotropic Effects, Potential for Metabolic Reprogramming and Prospects for the Future.
Daniel L Pouliquen, Koraljka Gall Trošelj, Ruby John Anto

Pharmaceutics· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment.
Chenicheri Kizhakkeveettil Keerthana, Tennyson Prakash Rayginia, Sadiq Chembothumparambil Shifana, Nikhil Ponnoor Anto, Kalishwaralal Kalimuthu, Ruby John Anto

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis.
Anwar Shabna, Jayesh Antony, Vinod Vijayakurup, Minakshi Saikia, Vijayasteltar B Liju, Nikhil Ponnoor Anto, Ruby John Anto

Cell Mol Life Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of exhibits anti-melanoma potential.
Sreekumar Usha Devi Aiswarya, Gowda Vikas, Nair Hariprasad Haritha, Vijayasteltar Belsamma Liju, Anwar Shabna, Nikhil Ponnoor Anto, Ruby John Anto

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma.
Lekshmi R Nath, Mundanattu Swetha, Vinod Vijayakurup, Arun Kumar Thangarasu, Nair Hariprasad Haritha, Ruby John Anto

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cucurbitacin B, Purified and Characterized From the Rhizome of Exhibits Anti-Melanoma Potential.
Sreekumar Usha Devi Aiswarya, Gowda Vikas, Nair Hariprasad Haritha, Vijayasteltar Belsamma Liju, Anwar Shabna, Nikhil Ponnoor Anto, Ruby John Anto

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma.
Mundanattu Swetha, Chenicheri K Keerthana, Tennyson P Rayginia, Lekshmi R Nath, Nair Hariprasad Haritha, Nikhil Ponnoor Anto, Ruby John Anto

Pharmaceuticals (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The emerging role of selenium metabolic pathways in cancer: New therapeutic targets for cancer.
Kalishwaralal Kalimuthu, Chenicheri K Keerthana, Manikandan Mohan, Jaison Arivalagan, Johnson Retnaraj Samuel Selvan Christyraj, Ruby John Anto

J Cell Biochem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of Uttroside B-Induced Autophagic Pro-Survival Signals Augments Its Chemotherapeutic Efficacy Against Hepatocellular Carcinoma.
Lekshmi R Nath, Mundanattu Swetha, Vinod Vijayakurup, Arun Kumar Thangarasu, Nair Hariprasad Haritha, Ruby John Anto

Front Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Chemoprevention: A Strategic Approach Using Phytochemicals.
Mohan Shankar G, Mundanattu Swetha, C K Keerthana, Tennyson P Rayginia, Ruby John Anto

Front Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy.
Nair Hariprasad Haritha, Akbar Nawab, Vinod Vijayakurup, Nikhil Ponnoor Anto, Vijayasteltar B Liju, Ruby John Anto

Front Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virtual screening-based identification of novel fatty acid synthase inhibitor and evaluation of its antiproliferative activity in breast cancer cells.
A Amrutha Nisthul, P R Archana, Ruby John Anto, C Sadasivan

J Mol Graph Model· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Evaluation of uttroside B, a saponin from Solanum nigrum Linn, as a promising chemotherapeutic agent against hepatocellular carcinoma.
Lekshmi R Nath, Jaggaiah N Gorantla, Arun Kumar T Thulasidasan, Vinod Vijayakurup, Shabna Shah, Jayesh Antony, Ruby John Anto

Sci Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Periostin/Integrin-αv Axis Regulates the Size of Hematopoietic Stem Cell Pool in the Fetal Liver.
Atreyi Biswas, Irene M Roy, Prathibha C Babu, Javed Manesia, Sarah Schouteden, Ruby John Anto

Stem Cell Reports· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An and Approach.
Bhagyalakshmi Nair, Ruby John Anto, Sabitha M, Lekshmi R Nath

Adv Pharm Bull· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer.
Mohan Shankar G, Vijai V Alex, Amrutha Nisthul A, Smitha V Bava, Sankar Sundaram, Ruby John Anto

Cell Prolif· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis